CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance... Show more
CNA Financial Corporation has largely consolidated over the past month, with shares hovering near the $48 level after a modest dip in late September. The stock sits within a 52-week range of roughly $41.53 to $55.71, with a market capitalization near $12.7 billion. The company's quarterly dividend of $0.48 per share translates to an annualized payout of $1.92 and a yield of about 4%, which has helped anchor investor interest during a period of subdued price momentum.
Broader sentiment across the property and casualty insurance sector remains mixed as carriers contend with elevated loss costs, social inflation in long-tail liability lines, and competitive pricing in commercial property. Against this backdrop, CNA's emphasis on underwriting discipline and balance-sheet strength has positioned it as a more defensive name within the commercial insurance group.
CNA Financial is a leading U.S. commercial property and casualty insurer headquartered in Chicago, Illinois, and a majority-owned subsidiary of Loews Corporation (L). The company underwrites coverage primarily through its Specialty, Commercial, and International segments, alongside a smaller Life & Group business.
Its product portfolio spans workers' compensation, general liability, commercial auto, professional liability and errors and omissions, excess casualty, property, and surety, distributed through independent agents and brokers to middle-market and large businesses. CNA's competitive strengths include a diversified commercial book, meaningful scale in specialty lines, a strong statutory capital position, and a growing stream of net investment income that provides an offset to underwriting volatility. Investors follow the stock for its dividend, its defensive business model, and management's ability to navigate the insurance pricing cycle.
The most significant recent catalyst came with second-quarter 2026 results reported in early August, when CNA posted core earnings of $1.19 per share—ahead of consensus estimates—on revenue of about $3.46 billion, up roughly 3% year over year. Property and casualty net written premiums increased about 4% to $2.97 billion, supported by a record $718 million of new business, up 11%.
Underwriting margins narrowed, however, with the property and casualty combined ratio rising 240 basis points to 96.5%, reflecting a higher loss ratio of 66.4% and catastrophe losses of $60 million. This followed first-quarter actions in which management added prudence to reserves in excess casualty and professional errors and omissions lines, citing social inflation and adverse loss-cost trends. CEO Douglas Worman has framed these moves as appropriate for the current liability environment and has emphasized a commitment to sustainable underwriting performance.
Institutional activity has also remained a factor. Regulatory filings in mid-October disclosed a newly established position by 1834 Investment Advisors during the third quarter, underscoring continued professional interest in the name. With third-quarter earnings scheduled for early November, investors are now looking ahead to signs of stabilization in reserve development and loss ratios across long-tail casualty lines.
Tickeron's Trending AI Robots page highlights a curated selection of algorithmic trading strategies that have recently demonstrated notable performance. Tickeron offers hundreds of AI-powered trading bots that monitor thousands of tickers across a wide range of markets, but only the top-performing and most relevant bots are featured in this section. These bots differ in their underlying strategy, holding timeframe, and performance metrics, giving traders a way to compare approaches before committing capital. Exploring the page can help investors identify data-driven signals and diversify the tools they use to evaluate opportunities in names such as CNA.
Looking ahead, the central question for CNA is whether its reserve actions prove sufficient against persistent social inflation and rising loss costs in excess casualty and professional liability lines. Investors will monitor the underlying loss ratio, reserve development, and the property and casualty combined ratio in upcoming quarters for evidence of stabilization. Premium growth and pricing power also remain in focus, particularly given management's selective approach—pursuing accretive classes while reducing exposure in competitive areas such as national accounts property.
Other factors include catastrophe-season losses, which can introduce quarterly volatility, and net investment income, which benefits from higher reinvestment rates but remains sensitive to limited partnership and equity returns. The upcoming third-quarter earnings report, guidance commentary, and any changes to the dividend will be closely watched. While the company's defensive positioning and steady payout provide a degree of stability, near-term performance will hinge on underwriting execution and the broader direction of commercial insurance pricing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for CNA turned positive on October 06, 2026. Looking at past instances where CNA's MACD turned positive, the stock continued to rise in 31 of 50 cases over the following month. The odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CNA as a result. In 54 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
CNA moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNA crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 55%.
Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNA advanced for three days, in 165 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 102 of 237 cases where CNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
The 10-day RSI Indicator for CNA moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 25 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 62 cases where CNA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
CNA broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock better than average.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.178) is normal, around the industry mean (-2.266). P/E Ratio (10.675) is within average values for comparable stocks, (9.149). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.303). Dividend Yield (0.039) settles around the average of (0.026) among similar stocks. P/S Ratio (0.881) is also within normal values, averaging (1.594).
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating fairly steady price growth. CNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of property, casualty, and health insurance products and services
Industry PropertyCasualtyInsurance